Creative Capital Strategies for Life Sciences Companies: Maximizing Funding Opportunities Throughout the Development Process

Unlearning to Innovate

Join us on July 17th to discuss a shift in the way leaders should be thinking about innovation.

After S211: What’s Next for Supply Chain Due Diligence?

Join us as we explore findings from the analysis of hundreds of S-211 filings, recent research on supply chain due diligence practices and detention readiness, and best practices to ensure your company is embedding responsible business practices across its operations.

Non-Dilutive Funding & Valuable Resources: Strategies for Growth Without Giving Up Equity

Join our professionals as they delve into the intricacies of non-dilutive funding, covering a range of opportunities from grants to government contracts and beyond.

Navigating the IPO Landscape in Life Sciences: Strategies for Success Amid Market Volatility

This insightful webcast, designed specifically for professionals in the life sciences sector, aims to equip you with the knowledge and strategies to navigate the IPO process in a less favorable economic climate.

Strategic Decision Making in the Life Sciences Industry: Managing the Build vs. Buy Dilemma

Join us for an insightful webcast that not only explores the make vs. buy decision but also delves into the strategic role of CDMOs across the life sciences industry. 

Fortifying Cybersecurity in Life Sciences: A Comprehensive Approach

In an era where digital transformation is not just an advantage but a necessity, life sciences companies are increasingly becoming targets for cyber threats and data breaches.

Harnessing Opportunities within Innovative Project Delivery

This webcast delves into the transformative potential of Public-Private Partnerships (P3s) under the Infrastructure Investment and Jobs Act (IIJA). Discover how strategic alignment with IIJA provisions can open new avenues for funding and enhance the execution of complex infrastructure projects through innovative delivery methods.

Leveraging 80/20 for Strategic Success

We would like to extend this invitation to our webcast "Leveraging 80/20 for Strategic Success" where we will explore the significant impact of the 80/20 principle on business strategy and operational efficiency.

Navigating Strategic Alliances in a Changing Economy

Workplace Strategy: Creating a Competitive Edge

How to Build a Work Environment that Balances the Needs of the Business With Those of its Employees

Taking Stock of Private Equity Mid-2023

Join BDO’s Private Equity Leaders for a discussion on where private equity sits midway through the year, informed by takeaways from our latest survey of more than 400 fund managers and operating partners and 250 portfolio company CFOs and board members.

Navigating the Noise: Enhancing Supply Chain Resilience and Addressing Regulatory Compliance

Please join us for a webcast on June 20th hosted by BDO USA and Sourcemap. Navigating the Noise: Enhancing Supply Chain Resilience and Addressing Regulatory Compliance, to learn actionable steps organizations can take to bolster resilience and improve supply chain transparency to meet new regulatory requirements.

80/20 Executive Community: Profitability Drivers for Informed Decision Making

The 80/20 toolbox contains a broad spectrum of resources, allowing organizations to accelerate their analysis and related transformations. Join us on our upcoming webcast where our panel of 80/20 practitioners and C-Suite leaders will share their insights.

Privacy and Website Compliance - Cookies, Consent, Tracking, Oh My!

Join the final webcast of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

Interpretation of BARDA’s Priorities for 2023: Preparedness for the Next Pandemic Threat

This webinar will provide a review of the highlights from BARDA Industry Day 2022, presentation of new initiatives to support pandemic preparedness, and recommendations of best practices for potential partners to be well positioned to respond to new opportunities.

Health Apps and HIPAA Business Associates’ Rising Obligations in Privacy and Health Data

Join our second webcast of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

HIPAA Privacy and Security: Recent Trends in Regulation, Enforcement, and Risk Management

Join this first webinar of BDO’s Healthcare and Life Sciences Data Protection Webinar Series to learn more about how organizations can address their efficiency, risk, and governance challenges by aligning approaches and functions to optimize compliance and leverage available protections.

The Evolving Federal Funding Landscape and Business Implications for the Life Sciences Industry

As Federal Government Agencies tasked with biodefense and public health continue response efforts to the acute phase of the COVID-19 pandemic, each Agency continues to balance strategic legacy initiatives and new fiscal year priorities.

What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks

With over 200 SPAC and IPO’s over the last year, SPACs are hotter than ever. US stocks continue to be unpredictable, finding the right opening to debut on Wall Street can be tricky and costly. But are SPAC’s the right approach for most Life Sciences companies seeking capital.

Federal Government Funding Opportunities for the Life Sciences Industry

The federal government has prioritized R&D for Covid-19 response efforts and will continue to do so until the health threat has been addressed. As these countermeasures are developed and deployed, the federal government’s biodefense R&D resources will be re-prioritized to address chemical, biological, radiological and nuclear threats, influenza and other emerging infectious diseases.

Life Sciences and the Technical/GxP Virtual Audit – The Show Must Go On

In the face of COVID-19, the mission becomes even more critical. Innovation such as finding a way to continue to work without interruption due to CDC protocols, such as social distancing and travel bans, is imperative. Thanks to leveraging technology, we have made it possible to perform audits from a remote location, a method known as the “virtual audit”.

2020 BDO Biotech Briefing

BDO’s annual Biotech Briefing examines the most recent 10-K SEC filings of companies listed on the NASDAQ Biotechnology Index. Join us as we analyze this year's findings and trends in the marketplace

Planning for a Return to Work: Considerations and Implications for the Life Sciences Industry

As the COVID-19 pandemic progresses, many executives are starting to rationalize how their teams safely return to work. With restrictions varying between regions and countries, it can be difficult to develop a comprehensive strategy. This challenge is further compounded by economic uncertainty and supplier dependencies.